EOPSF yields 34.13% · JNJ yields 2.14%● Live data
📍 EOPSF pulled ahead of the other in Year 1
Combined, EOPSF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EOPSF + JNJ for your $10,000?
Electro Optic Systems Holdings Limited engages in the development, manufacture, and sale of telescopes and dome enclosures, laser satellite tracking systems, electro-optic fire control systems, and microwave satellite dishes and receivers. It operates through three segments: Defense, Space, and Communication. The Defense segment develops, manufactures, and markets fire control, surveillance, and weapon systems to military customers, as well as sensors and fire control software products. The Space segment designs, manufactures, delivers, and operates sensors and systems for space domain awareness and space control. Its products include space debris management systems, defense missiles, optical communications systems, and space products consisting of observatories, telescopes, and laser products and electronics. The Communication segment offers optical, microwave, and on-the-move radio and satellite systems. It operates in Australasia, the Middle East, the United Arab Emirates, North America, Europe, and others. The company was founded in 1983 and is based in Symonston, Australia.
Full EOPSF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.